Deutsche Märkte geschlossen

Sensus Healthcare, Inc. (SRTS)

NasdaqCM - NasdaqCM Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
5,93-0,49 (-7,63%)
Börsenschluss: 04:00PM EDT
6,00 +0,07 (+1,18%)
Nachbörse: 07:38PM EDT

Sensus Healthcare, Inc.

851 Broken Sound Parkway NW
Suite 215
Boca Raton, FL 33487
United States
561 922 5808
https://sensushealthcare.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter35

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Joseph C. SardanoCo-Founder, Chairman & CEO687,6kN/A1953
Mr. Michael J. SardanoPresident, General Counsel, Corporate Secretary & Director362,93kN/A1988
Mr. Javier RampollaChief Financial Officer357,06kN/A1973
Ms. Magdalena MartinezChief Operating OfficerN/AN/A1990
Mr. Emiliano SosaChief Technology OfficerN/AN/A1978
Ms. Stephanie TiptonVice President of MarketingN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Corporate Governance

Sensus Healthcare, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.